http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1154775-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4953
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-39
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
filingDate 2000-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2003-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_095ce2ef83b160aeead3a10382b909d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56c1124486317cada2bbb2633a8dfa14
publicationDate 2003-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1154775-B1
titleOfInvention Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
abstract The invention provides a therapeutic aqueous composition comprising: (i) a therapeutically effective amount of a hexahydro-5-pyrimidinamine compound, e.g. hexetidine; (ii) a salification acidic compound; and (iii) a polyalkoxylated fatty alcohol. The composition shows enhanced stability.
priorityDate 1999-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID103023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23440335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128080043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10953859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226516748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409824
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129321579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127785180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127530547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24181110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128499823

Total number of triples: 55.